Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020423 |
---|---|
Receipt number | R000023585 |
Scientific Title | The OCEAN-TAVI registry (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) |
Date of disclosure of the study information | 2016/01/04 |
Last modified on | 2023/07/11 21:44:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/01/04 09:13:53 | ||
2 | Update | 2016/01/28 19:31:42 | Public title |
|
3 | Update | 2016/01/28 19:35:02 | Other related information |
|
4 | Update | 2017/03/15 16:33:27 | Public title |
|
5 | Update | 2017/03/15 16:42:42 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 |
|
6 | Update | 2018/01/23 15:59:24 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 Target sample size |
|
7 | Update | 2018/01/23 16:03:41 | Other related information Other related information |
|
8 | Update | 2019/07/08 09:10:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
9 | Update | 2019/07/08 09:16:15 | Date of IRB Anticipated trial start date Last follow-up date Other related information Other related information |
|
10 | Update | 2020/01/07 09:24:36 | Organization Organization |
|
11 | Update | 2020/01/07 09:26:53 | Last follow-up date Other related information Other related information |
|
12 | Update | 2020/02/03 09:31:22 | Primary outcomes |
|
13 | Update | 2020/02/03 09:33:08 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
14 | Update | 2020/02/03 09:37:42 | Key exclusion criteria Key exclusion criteria |
|
15 | Update | 2020/02/03 15:24:15 | Primary outcomes Primary outcomes |
|
16 | Update | 2020/02/03 15:25:08 | Last follow-up date |
|
17 | Update | 2020/06/11 14:00:21 | Key inclusion criteria |
|
18 | Update | 2020/06/15 16:55:31 | Organization Organization |
|
19 | Update | 2020/07/15 23:39:23 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
20 | Update | 2020/07/15 23:41:48 | Narrative objectives1 Narrative objectives1 Trial characteristics_1 Trial characteristics_2 Developmental phase Key secondary outcomes Key secondary outcomes |
|
21 | Update | 2020/07/15 23:43:20 | Developmental phase Key secondary outcomes |
|
22 | Update | 2020/07/15 23:45:36 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
23 | Update | 2020/07/15 23:51:07 | Organization Division name Division name Zip code Address Address Organization Division name Division name Zip code Address Address Division name Address Address Institute Institute Organization Organization Address1 Address Address |
|
24 | Update | 2020/07/15 23:52:14 | Anticipated trial start date Other related information Other related information |
|
25 | Update | 2021/09/14 10:22:00 | Name of person sending information Name of person sending information Organization Organization Division name Address Address TEL Organization Organization |
|
26 | Update | 2021/09/15 13:43:57 | UMIN ID1 |
|
27 | Update | 2022/07/11 12:37:01 | Other related information Other related information |
|
28 | Update | 2023/07/11 21:44:23 | Name of person sending information Name of person sending information |